Dr. Patrick C. Ma is the Associate Director of Translational Research and Thoracic Oncology Multidisciplinary Disease Team Leader of the Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Penn State University in Hershey, Pennsylvania, USA. He is a Professor of Medicine and Microbiology & Immunology, and holds the Frank and Franco Cancer Research Endowment. He is also co-leader of the Next Generation Therapies Program. Dr. Ma is a medical oncologist and has broad expertise in clinical and translational cancer investigations. Dr. Ma’s research focuses on developing novel therapies for thoracic malignancies and understanding of the molecular mechanisms and determinants of response and resistance. He has considerable expertise in translational and clinical research in lung cancer targeted therapies involving oncogenic kinases of EGFR, ALK and MET. His earlier work led to the first and seminal discovery of MET exon 14 skipping oncogenic mutations (METex14). Dr. Ma’s laboratory research emphasizes on biomarkers development in targeted therapy and immunotherapy, using state-of-the-art molecular and omics platforms including single cell analysis. Dr. Ma was a recipient of prestigious awards including Cleveland Clinic Lerner Research Institute Chair’s Innovative Research Award, DOD Lung Cancer Promising Clinician Research Grant Award. He was also winner of the WVU Medicine – Press Ganey Top Provider Award 2018 (Top 2%).